A New Chapter: How 2023 Will Shape the US Biosimilar Space for 2024 and Beyond

Season 6, Episode 23,   Dec 31, 2023, 12:00 PM

On this episode of Not So Different, Cencora's Brian Biehn and Corey Ford take a look back at major policy and regulatory advancements in 2023 and how these changes will change the space going forward.

Show notes

To learn more about the prospect for Neulasta OnPro biosimilars, click here.
To learn more about how the IRA will impact biosimilars, click here
To learn more about the dual-pricing strategy being used for adalimumab biosimilars, click here.
To hear Brian's insight into how the ophthalmology biosimilar industry is developing, click here.
To listen to previous Not So Different episodes featuring more of Brian's insight into how the adalimumab market will develop and biosimilar pricing trends, click here or here.